Cargando…
Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma
OBJECTIVE: Esophageal squamous cell carcinoma (ESCC) is a common and aggressive malignancy of the gastrointestinal tract for which therapeutic options are scarce. This study screens for LOXL2, a key gene in ESCC, and explains the molecular mechanism by which it promotes the progression of ESCC. METH...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293450/ https://www.ncbi.nlm.nih.gov/pubmed/36995521 http://dx.doi.org/10.1007/s12094-023-03133-5 |
_version_ | 1785063005287874560 |
---|---|
author | Fan, Zhiqin Liu, Yingmin Liu, Xinya Nian, Wei Huang, Xiaotong Yang, Qianqian Hou, Songyu Chen, Fei |
author_facet | Fan, Zhiqin Liu, Yingmin Liu, Xinya Nian, Wei Huang, Xiaotong Yang, Qianqian Hou, Songyu Chen, Fei |
author_sort | Fan, Zhiqin |
collection | PubMed |
description | OBJECTIVE: Esophageal squamous cell carcinoma (ESCC) is a common and aggressive malignancy of the gastrointestinal tract for which therapeutic options are scarce. This study screens for LOXL2, a key gene in ESCC, and explains the molecular mechanism by which it promotes the progression of ESCC. METHODS: Immunohistochemical staining was performed to detect the expression level of LOXL2 in ESCC tissues and paraneoplastic tissues. CCK-8 and Transwell assays were performed to assess the effects of LOXL2 knockdown and overexpression on the proliferation, apoptosis, migration and invasion ability of ESCC cells. High-throughput sequencing analysis screens for molecular mechanisms of action by which LOXL2 promotes ESCC progression. Western blotting and qRT-PCR were used to determine the expression levels of relevant markers. RESULTS: LOXL2 is positively expressed in ESCC and highly correlated with poor prognosis. Silencing LOXL2 significantly inhibited the proliferation, migration and invasive ability of ESCC cells, whereas overexpression showed the opposite phenotype. High-throughput sequencing suggested that LOXL2-associated differentially expressed genes were highly enriched in the PI3K/AKT signaling pathway. In vitro cellular assays confirmed that silencing LOXL2 significantly reduced PI3K, p-AKT(Thr308) and p-AKT(Ser473) gene and protein expression levels, while overexpression increased all three gene and protein levels, while AKT gene and protein expression levels were not significantly different. CONCLUSION: This study found that LOXL2 may regulate the PI3K/AKT signaling pathway and exert protumor effects on ESCC cells through phosphorylation of AKT. LOXL2 may be a key clinical warning biomarker or therapeutic target for ESCC. |
format | Online Article Text |
id | pubmed-10293450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-102934502023-06-28 Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma Fan, Zhiqin Liu, Yingmin Liu, Xinya Nian, Wei Huang, Xiaotong Yang, Qianqian Hou, Songyu Chen, Fei Clin Transl Oncol Research Article OBJECTIVE: Esophageal squamous cell carcinoma (ESCC) is a common and aggressive malignancy of the gastrointestinal tract for which therapeutic options are scarce. This study screens for LOXL2, a key gene in ESCC, and explains the molecular mechanism by which it promotes the progression of ESCC. METHODS: Immunohistochemical staining was performed to detect the expression level of LOXL2 in ESCC tissues and paraneoplastic tissues. CCK-8 and Transwell assays were performed to assess the effects of LOXL2 knockdown and overexpression on the proliferation, apoptosis, migration and invasion ability of ESCC cells. High-throughput sequencing analysis screens for molecular mechanisms of action by which LOXL2 promotes ESCC progression. Western blotting and qRT-PCR were used to determine the expression levels of relevant markers. RESULTS: LOXL2 is positively expressed in ESCC and highly correlated with poor prognosis. Silencing LOXL2 significantly inhibited the proliferation, migration and invasive ability of ESCC cells, whereas overexpression showed the opposite phenotype. High-throughput sequencing suggested that LOXL2-associated differentially expressed genes were highly enriched in the PI3K/AKT signaling pathway. In vitro cellular assays confirmed that silencing LOXL2 significantly reduced PI3K, p-AKT(Thr308) and p-AKT(Ser473) gene and protein expression levels, while overexpression increased all three gene and protein levels, while AKT gene and protein expression levels were not significantly different. CONCLUSION: This study found that LOXL2 may regulate the PI3K/AKT signaling pathway and exert protumor effects on ESCC cells through phosphorylation of AKT. LOXL2 may be a key clinical warning biomarker or therapeutic target for ESCC. Springer International Publishing 2023-03-30 2023 /pmc/articles/PMC10293450/ /pubmed/36995521 http://dx.doi.org/10.1007/s12094-023-03133-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Fan, Zhiqin Liu, Yingmin Liu, Xinya Nian, Wei Huang, Xiaotong Yang, Qianqian Hou, Songyu Chen, Fei Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma |
title | Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma |
title_full | Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma |
title_fullStr | Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma |
title_full_unstemmed | Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma |
title_short | Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma |
title_sort | phosphorylation of akt by lysyl oxidase-like 2 activates the pi3k/akt signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293450/ https://www.ncbi.nlm.nih.gov/pubmed/36995521 http://dx.doi.org/10.1007/s12094-023-03133-5 |
work_keys_str_mv | AT fanzhiqin phosphorylationofaktbylysyloxidaselike2activatesthepi3kaktsignalingpathwaytopromoteproliferationinvasionandmetastasisinesophagealsquamouscarcinoma AT liuyingmin phosphorylationofaktbylysyloxidaselike2activatesthepi3kaktsignalingpathwaytopromoteproliferationinvasionandmetastasisinesophagealsquamouscarcinoma AT liuxinya phosphorylationofaktbylysyloxidaselike2activatesthepi3kaktsignalingpathwaytopromoteproliferationinvasionandmetastasisinesophagealsquamouscarcinoma AT nianwei phosphorylationofaktbylysyloxidaselike2activatesthepi3kaktsignalingpathwaytopromoteproliferationinvasionandmetastasisinesophagealsquamouscarcinoma AT huangxiaotong phosphorylationofaktbylysyloxidaselike2activatesthepi3kaktsignalingpathwaytopromoteproliferationinvasionandmetastasisinesophagealsquamouscarcinoma AT yangqianqian phosphorylationofaktbylysyloxidaselike2activatesthepi3kaktsignalingpathwaytopromoteproliferationinvasionandmetastasisinesophagealsquamouscarcinoma AT housongyu phosphorylationofaktbylysyloxidaselike2activatesthepi3kaktsignalingpathwaytopromoteproliferationinvasionandmetastasisinesophagealsquamouscarcinoma AT chenfei phosphorylationofaktbylysyloxidaselike2activatesthepi3kaktsignalingpathwaytopromoteproliferationinvasionandmetastasisinesophagealsquamouscarcinoma |